We are live on ! Find out more
NAUT icon

Nautilus Biotechnolgy
NAUT

56 hedge funds and large institutions have $380M invested in Nautilus Biotechnolgy in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

130% more capital invested

Capital invested by funds: $165M → $380M (+$214M)

100% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 12

50% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 10

27% more funds holding

Funds holding: 44 → 56 (+12)

18% more call options, than puts

Call options by funds: $294K | Put options by funds: $250K

46.2% less ownership

Funds ownership: 77.66% → 31.46% (-46%)

Holders
56
Holders Change
+12
Holders Change %
+27.27%
% of All Funds
0.97%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
24
Increased
15
Reduced
10
Closed
12
Calls
$294K
Puts
$250K
Net Calls
+$44K
Net Calls Change
+$46K

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$96.5M
2
MVG
Madrona Venture Group
Washington
+$65.2M
3
CFM
Comprehensive Financial Management
California
+$24.1M
4
ABG
Ally Bridge Group
New York
+$16.2M
5
RCM
RA Capital Management
Massachusetts
+$16.2M

Top Sellers

Rank Fund Capital Flow
1
AWG
Alpha Wave Global
New York
-$8.39M
2
BCM
BlueCrest Capital Management
Jersey
-$7.78M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.77M
4
ESCM
Echo Street Capital Management
New York
-$3.95M
5
ACM
Altium Capital Management
New York
-$3.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$1.75M -$203K -18,717 -10%
CS
27
Candriam SCA
Luxembourg
$1.57M +$1.68M +155,000 New
AGM
28
Alpine Global Management
New York
$1.46M +$1.56M +144,124 New
Marshall Wace
29
Marshall Wace
United Kingdom
$679K +$728K +67,198 New
Geode Capital Management
30
Geode Capital Management
Massachusetts
$660K +$708K +65,397 New
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$655K -$721K -66,610 -51%
BM
32
Bridger Management
New York
$576K +$617K +57,000 New
GL
33
Governors Lane
New York
$561K -$1.49M -137,692 -71%
LOAMU
34
Lombard Odier Asset Management (USA)
New York
$505K +$542K +50,000 New
PCM
35
Prelude Capital Management
New York
$500K +$536K +49,500 New
HF
36
HRT Financial
New York
$432K +$140K +12,953 +43%
CC
37
Clearline Capital
New York
$415K +$445K +41,112 New
Millennium Management
38
Millennium Management
New York
$385K +$192K +17,760 +87%
SGM
39
Skye Global Management
Florida
$354K +$108K +10,000 +40%
CAC
40
Cowen and Company
New York
$303K +$325K +30,000 New
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$268K +$287K +26,536 New
RJA
42
Raymond James & Associates
Florida
$161K +$47.6K +4,394 +38%
Verition Fund Management
43
Verition Fund Management
Connecticut
$152K -$390K -36,037 -71%
FIA
44
FNY Investment Advisers
New York
$50K +$54.2K +5,000 New
PCM
45
Penserra Capital Management
California
$48K -$13K -1,199 -20%
APA
46
American Portfolios Advisors
New York
$34.7K – – –
CSS
47
Cubist Systematic Strategies
Connecticut
$28K +$29.8K +2,750 New
Simplex Trading
48
Simplex Trading
Illinois
$21K +$23.2K +2,140 New
Bank of America
49
Bank of America
North Carolina
$15K +$16.2K +1,500 New
Citigroup
50
Citigroup
New York
$12K – – –
1
2
3

NAUT Hedge Fund Activity: Q2 2021 in Review

56 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q2 2021, worth a combined $380M — up 130% from $165M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new NAUT positions and 12 closed out — a net gain of 12 holders — while 15 added to existing stakes and 10 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $96.5M. The largest seller was Alpha Wave Global, exiting entirely with an estimated $8.39M sold.

  • 56 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q2 2021, up from 44 in Q1 2021.
  • Funds reported $380M of Nautilus Biotechnolgy stock for Q2 2021, up 130% quarter-over-quarter.
  • 24 funds opened new Nautilus Biotechnolgy positions in Q2 2021 and 12 closed out, a net change of +12 holders.
  • The largest Nautilus Biotechnolgy buyer in Q2 2021 was Perceptive Advisors, an estimated $96.5M added.
  • The largest Nautilus Biotechnolgy seller in Q2 2021 was Alpha Wave Global, an estimated $8.39M sold.

Based on aggregated 13F filings for Q2 2021.